My thinking is that this guy was brought in the past two weeks to consult on something the FDA peeps probably did not have sufficient expertise on to provide eval on our Y-90 gel device. Makes perfect sense to me. One of his publications clearly goes to what AMIC does. This is no coincidence to me, especially given the timing of this. It doesn't take one to read between the lines and consider that this guy was tapped for a reason.
News 
Market Data 
Discover 
